Avoro Capital Advisors LLC Q1 2021 Filing
Filed May 17, 2021
Portfolio Value
$5.8T
Holdings
46
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (46 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HZNPHORIZON THERAPEUTICS PLC | 9,000,000 | $828.4B | 14.31% | |
| 2 | MRTXEURMIRATI THERAPEUTICS INC | 4,675,000 | $800.8B | 13.83% | |
| 3 | UTHUNITED THERAPEUTICS CORP | 3,000,000 | $501.8B | 8.67% | |
| 4 | XLRNACCELERON PHARMA INC | 3,000,000 | $406.8B | 7.03% | |
| 5 | VRTXVERTEX PHARMACEUTICALS INC | 1,400,000 | $300.8B | 5.20% | |
| 6 | ARNAEURARENA PHARMACEUTICALS INC | 4,050,000 | $281.0B | 4.85% | |
| 7 | ARGXARGENX SE | 925,500 | $254.9B | 4.40% | |
| 8 | IOVAIOVANCE BIOTHERAPEUTICS INC | 8,000,000 | $253.3B | 4.37% | |
| 9 | —ASCENDIS PHARMA | 1,900,000 | $244.9B | 4.23% | |
| 10 | MDGLMADRIGAL PHARMACEUTICALS INC | 1,425,000 | $166.7B | 2.88% | |
| 11 | SRPTSAREPTA THERAPEUTICS INC | 2,150,000 | $160.2B | 2.77% | |
| 12 | BMRNBIOMARIN PHARMACEUTICAL INC | 1,650,000 | $124.6B | 2.15% | |
| 13 | AM6AMICUS THERAPEUTICS INC | 12,250,000 | $121.0B | 2.09% | |
| 14 | KURAKURA ONCOLOGY INC | 4,000,000 | $113.1B | 1.95% | |
| 15 | —MERSANA THERAPEUTICS INC | 6,800,000 | $110.0B | 1.90% | |
| 16 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 8,000,000 | $78.9B | 1.36% | |
| 17 | PMVPPMV PHARMACEUTICALS INC | 2,360,267 | $77.6B | 1.34% | |
| 18 | —CONSTELLATION PHARMACEUTICALS INC | 2,950,000 | $69.0B | 1.19% | |
| 19 | XENEXENON PHARMACEUTICALS INC | 3,650,000 | $65.3B | 1.13% | |
| 20 | ACADACADIA PHARMACEUTICALS INC | 2,500,000 | $64.5B | 1.11% | |
| 21 | TREURTRILLIUM THERAPEUTICS INC | 5,700,000 | $61.2B | 1.06% | |
| 22 | SNDXSYNDAX PHARMACEUTICALS INC | 2,500,000 | $55.9B | 0.97% | |
| 23 | RLMDRELMADA THERAPEUTICS INC | 1,525,000 | $53.7B | 0.93% | |
| 24 | MRNS*MARINUS PHARMACEUTICALS INC | 3,235,000 | $50.1B | 0.86% | |
| 25 | PRAXPRAXIS PRECISION MEDICINES INC | 1,596,495 | $47.4B | 0.82% | |
| 26 | CBAYUSDCYMABAY THERAPEUTICS INC | 10,300,000 | $46.8B | 0.81% | |
| 27 | OPHTEURIVERIC BIO INC | 7,250,000 | $44.8B | 0.77% | |
| 28 | APLSAPELLIS PHARMACEUTICALS INC | 1,000,000 | $42.9B | 0.74% | |
| 29 | DCPHEURDECIPHERA PHARMACEUTICALS INC | 893,000 | $40.0B | 0.69% | |
| 30 | DSGNDESIGN THERAPEUTICS INC | 1,468,318 | $39.7B | 0.69% | |
| 31 | AVDLAVADEL PHARMACEUTICALS PLC | 4,365,000 | $39.5B | 0.68% | |
| 32 | AMRNAMARIN CORP PLC | 6,000,000 | $37.3B | 0.64% | |
| 33 | TVTXTRAVERE THERAPEUTICS INC | 1,249,000 | $31.2B | 0.54% | |
| 34 | MNKDMANNKIND CORP | 7,500,000 | $29.4B | 0.51% | |
| 35 | OLMAOLEMA PHARMACEUTICALS INC | 876,986 | $24.6B | 0.42% | |
| 36 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 3,550,000 | $18.9B | 0.33% | |
| 37 | RLAYRELAY THERAPEUTICS INC | 500,000 | $17.3B | 0.30% | |
| 38 | MRUSMERUS N V | 665,000 | $13.9B | 0.24% | |
| 39 | GNCAQGENOCEA BIOSCIENCES INC | 5,084,184 | $13.8B | 0.24% | |
| 40 | RNAAVIDITY BIOSCIENCES INC | 545,000 | $11.9B | 0.21% | |
| 41 | BDTXBLACK DIAMOND THERAPEUTICS INC | 440,000 | $10.7B | 0.18% | |
| 42 | —THERAPEUTICS ACQUISITION CORP | 1,000,000 | $10.5B | 0.18% | |
| 43 | FRXFENNEC PHARMACEUTICALS INC | 1,670,000 | $10.4B | 0.18% | |
| 44 | —BCTG ACQUISITION CORP | 800,000 | $8.9B | 0.15% | |
| 45 | JNCEEURJOUNCE THERAPEUTICS INC | 555,000 | $5.7B | 0.10% | |
| 46 | GLPGGALAPAGOS NV | 3,100 | $239.0M | 0.00% |